ACM
LMAT icon

Aster Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Aster Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-46
Closed -$4.03K – 1284
2025
Q3 		$4.03K Buy
+46
New +$4.11K ﹤0.01% 827
2025
Q2 		– Sell
-3,863
Closed -$355K – 1339
2025
Q1 		$355K Buy
3,863
+3,664
+1,841% +$341K 0.07% 349
2024
Q4 		$18.3K Buy
+199
New +$19.1K 0.01% 650

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Aster Capital Management's LMAT Position: Q4 2025 in Review

Aster Capital Management sold out of LeMaitre Vascular (LMAT) in Q4 2025, closing a stake of 46 shares — an estimated $4.03K sold.

Aster Capital Management first reported a position in LMAT in Q4 2024 and held it in 3 quarters. The position peaked at $355K in Q1 2025. 297 funds tracked by Wall St. Rank hold LMAT as of Q4 2025.

  • Aster Capital Management reported no remaining LeMaitre Vascular position as of Q4 2025 after selling out during the quarter.
  • Aster Capital Management sold 46 LeMaitre Vascular shares in Q4 2025, an estimated $4.03K.
  • Aster Capital Management first reported a position in LeMaitre Vascular in Q4 2024 and held it in 3 quarters.
  • Aster Capital Management's LeMaitre Vascular position peaked at $355K in Q1 2025.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2025.

Based on Aster Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.